The pioneer factor FOXA1 also plays an important role in androgen receptor (AR) signaling of molecular apocrine tumors, which have been recently identified as an additional subgroup of ER-negative and AR-positive breast tumors (Ni et al. 2011; Robinson et al. 2011). This evidence concerns the gene FOXA1 and breast neoplasm.